Please log in to save bookmarks. Only registered users can save their favorite pages.
Journal Properties
Number of Articles
31
Abbreviation
BS
e-ISSN
2230-245X
Publisher
Informa UK Limited
Indian UGC
DOAJ (latest)
Description
Biosimilars is a peer-reviewed, open-access journal focused on the rapidly evolving field of biosimilars. It serves as a platform for researchers, clinicians, and industry professionals to share their knowledge and insights on the development, regulation, and clinical use of these important medicines. The journal's scope encompasses a wide range of topics related to biosimilars, including their characterization, manufacturing, clinical efficacy, safety, and regulatory pathways.
_Biosimilars_ welcomes submissions of original research articles, reviews, and perspectives that contribute to the understanding of the unique challenges and opportunities associated with biosimilar development. It emphasizes the importance of rigorous scientific evidence to support the approval and use of these medicines, ensuring patient safety and access to affordable treatment options.
By fostering dialogue and collaboration among stakeholders, _Biosimilars_ aims to advance the field and promote the responsible development and utilization of biosimilars to improve patient care and healthcare sustainability.